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Contribution of the Platelet Factor V Content
to Platelet Factor 3 Activitv
H. veN ZuleuEN, E. M. Bsvrns, H. C. HpMxsn nNo R. F. A. Zwtr.t
Department of Biochemistry, Biomedical Centre, State Uniuersity of Limburg,
Maastricht, The Netherlands
(Receiued 19June 1979; acceptedfor publication 16 Oaober 1979)
Suuuany. The procoagulant activity obtained from bovine thrombocytes has been
compared to that of lipids isolated from platelets, with and without the addition of
purified bovine factor V. A one-stage assay, which consisted of delipidated bovine
plasma containing RVV-activated factor X, was used to assess the activity. At low
lipid concentrations no difference in coagulant activity was found between sonicated
vesicles of extracted platelet lipid and lysed platelets. At higher lipid concentrations.
however, the extracted lipids were found to be less active than lysed platelets.
Determination of factor V in suspensions of gel-filtered platelets demonstrated that
suspensions containing 2x10e platelets per ml possessed about 1o/o of the factor V
activity present in a normal bovine plasma pool. Platelet lysis by sonication pro-
duced a five-fold increase in factor V activity. Addition of factor V to sonicated
vesicles ofextracted platelet lipid, so as to produce an identical factor V activity per
amount of lipid as found in lysed platelets, decreased the clotting time only in the
higher lipid concentration range. A further three-fold increase in the amount of
factor V added to the lipid vesicles made the coagulant properties of the lipid vesicles
indistinguishable from those of lysed platelets over the whole range of phospholipid
concentrations tested. When the conditions of the test were changed by diminishing
the concentration of factor Xa in the substrate plasma, the difference between lysed
platelets and extracted platelet lipid disappeared completely. It is concluded that the
higher coagulant activity of lysed platelets, as compared to that of extracted platelet
lipid, can be ascribed to platelet factor V activity. Therefore there is no compelling
necessity to postulate the existence of a specific procoagulant factor in the platelet
other than factor V or phospholipids.
Whether phospholipids and known clotting factors can account for the procoagulant activity
of blood platelets or that this activity arises from other platelet proteins as well, is a long-stand-
ing matter of debate. In 1966, it was reported that phospholipids extracted both from human
platelets and isolated platelet plasma membranes showed lower coagulant activities than the
membranes themselves (Marcus et al, 1966). This finding led the authors to conclude that
platelet phospholipid alone had less clot-promoting activity than the lipoprotein complexes in
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platelet membranes. It was also suggested that platelet factor 3, the coagulant activity which
becomes available during the platelet activation process, represented the activity of platelet
membrane lipoprotein rather than the clot*promoting activity of membrane phospholipids per
se (Marcus, 1969, 1978). Also, phosphatidylserine was found to be more active than other
phospholipids in providing intrinsic factor Xa-forming activity but this was not interpreted as
evidence that this phospholipid plays a specific role (Walsh & Biggs, 1972;Walsh,1978).
It has been known for several years that human platelets, separated from plasma by
high-speed centrifugation (Fljort et a\,7955) or albumin density gradient centrifugarion
('W"alsh, 1972), possess factor V activity, presumably representing plasma factor V bound to the
platelet. Recent studies with gel-filtered platelets have presented evidence that factor V is
localized within the intact normal human platelet rdther than being adsorbed to its surface
(Breederveld et a\,1,975; Osterud et a|,1977). Furthermore, it has been proposed that during
the platelet activation process activated (platelet) factor V becomes available at the platelet
surface (Osterud et a|,1977). This factor V activity seems to be related to the factor Xa binding
site which is exposed after platelet activation with small amounts of thrombin (M1letich et al,
1,977 , 7978a, b).
Platelet factor Va is evidently a first candidate among the platelet factors that could explain
the excess procoagulant activity reported by Marcus et al (1966). The purpose of the present
study was to investigate whether or not factors, other than factor V, need be postulated. In an
earlier paper (Tans et aI, 1,979) we reported studies on the clotting activity of various synthetic
mixtures of phosphatidylserine and phosphatidylcholine using a one-stage prothrombinase
assay with different phospholipid concentrations. In the present study this assay has been used
to compare the coagulant activities of lipids isolated from bovine platelets with that of lysed
platelets. The results indicate that the higher coagulant activity of lysed platelets need not be
ascribed to anything other than platelet factor V activity.
MATERIALS AND METHODS
Pr ep ar ation of Platelet Su sp ensions
800 ml of bovine blood was collected in 176 ml of a solution which was 0'183 u in glucose,
0.079 rvr in trisodium citrate and 0.051 u in citric acid. The blood was then centrifuged at250 g
for 25 min at room temperature and the platelet rich plasma (PRP) was collected. It was respun
at 250 g for 20 min in order to remove contaminating erythrocytes.
To separate the platelets from the plasma about 350 ml of PRP were applied to a column of
1500 ml of Sepharose 28 (Tangen & Berman , 1973). Elution of the column was carried out
with a 0'05 u Tris buffer, pH7.4, which contained 0.I2u NaCl. Fractions containing platelets
as judged by their turbidity were combined and counted by phase contrast microscopy. This
always showed 0.5-1,.0% of contaminating erythrocytes. The gel-filtered platelets (GFP) were
then pelleted by centrifugation at 1400 g for 30 min and resuspended in the eluant buffer. The
resulting platelet suspensions (2 x 10e platelets/ml) were kept at room temperature and used
immediately in coagulation assays. Platelet suspensions to be lysed later by sonication were
stored at -70"C. Siliconized glassware or plastic was used throughout the platelet isolation
procedure.
Platelet Factor V
Lipid Extracts and Lipid Analyses
Quantitative lipid extracts from known numbers of bovine platelets were made by meth-
anol-chloroform extraction (Reed et al, 1.960). The extracts were taken to dryness under
reduced pressure and the residues were weighed and dissolved in known volumes of carbon
tetrachloride-methanol (66:34 v/v). The lipid solutions were analysed for cholesterol (Webs-
tet,1.962) and phospholipid phosphorus (Bottcher et a|,1961). The phospholipid composition
was obtained from two-dimensional thin-layer chromatography (Broekhuyse, 1969) and lipid
phosphorus determination (Bottcher et al, 1.961). The lipid solutions were stored under
nitrogen at -20"C until use. Synthetic phospholipids were prepared as described recently
(Tans ef al, 1979). Phosphatidylinositol from plant was obtained from Applied Science
Laboratories Inc. Cholesterol was purchased from T. T. Baker.
Coagulation Assays
The procoagulant activities of bovine platelet suspensions and lipids extracted from the
platelets were measured in a one-stage prothrombinase assay as described in detail earlier (Tans
et a|,1979).0.1 ml delipidated bovine plasma (diluted five-fold with 0'05 rvr Tris, pH7'4,0'1,2rvr
NaCl) was incubated for 30 s with 0.1 ml factor X-activating enzyme from Russell's Viper
venom (RVV-X) and 0'1 ml CaClz (15 mrr,r) to achieve activation of factor X.0'1 ml of a
suspension of sonicated phospholipid vesicles was added in concentrations ranging from 1000
to 1 nmol/ml and the clotting time was measured. The concentration of RVV-X was used as
adjustable parameter to set the coagulation time at about 225 s when Tris buffer was added
instead of lipid vesicles. An identical range of phospholipid concentrations was used when
lysed platelet suspension was added instead of phospholipid vesicles. This was effected by
adjusting the platelet count of the suspension, prior to sonication, to2x I}e platelets/ml which
corresponds to approx. 1000 nmol phospholipid/ml, assuming an average molecular weight of
800 for the phospholipids (compare also Table I). Platelets were lysed by sonication for 3 min in
ice, using 15 s intervals with cooling periods of 15 s (Baenziger & Majerus, 1974).
Factor V was determined by a one-stage assay using factor V-deficient reagent (Borchgre-
vink el al,1960). The factor V concentration was expressed as a percentage of the content in a
normal bovine plasma pool. The factor V and factor Va preparations (activated by factor
V-activating enzynre from Russell's Viper venom) were kindly supplied by Dr M.J. Lindhout.
The factor X-deficient plasma (from a patient with congenital factor X deficiency) was kindly
donated by Dr B. N. Bouma, Academic Hospital, State university of (Jtrecht, Utrecht, The
Netherlands.
RESULTS
Lipid Composition of Bouine Blood Platelets
The number ofplatelets obtained from batches of 1 litre of bovine blood varied between 3
and 6x 1011. The lipid composition, expressed as ng per 10s platelets, is shown in Table I. Total
lipid based on dry weight was found to be higher than the sum ofphospholipid and cholesterol.
The difference can presumably be accounted for by triglycerides and glycolipids (Marcus e/ a/,
1969, 1.972). The weight ratio of phospholipid to cholesterol was approximately 3, which
corresponds to a molar ratio of 1'6.
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The phospholipid composition of whole bovine platelets which is shown in Table II, appears
to be rather similar to those reported forhuman and pig platelets (Marcus et al, 1969; Chap et al ,
1977\.
Tasrr I. Bovine platelet lipids
Lipid ngl105 platelets
Total lipid (dry weight)
Cholesterol
Phospholipid
Cholesterol a phospholipid
s1.s (49.8-s2.3)
11-6 (rr'4-11.e)
36.6 (36.r-37.7)
8.2 (47.s49.6)
The values given are the means of six
experiments. The values in parentheses indi-
cate the range.
Tarrn II. Phospholipid composition of
bovine platelets
Component
Percentage oJ
total phospholipid
Sphingomyelin
Phosphatidylcholine
Phosphatidylserine
Phosphatidylinositol
Phosphatidylethanolamine
25.8+ 1.9
33.3+2.4
7.0+0.5
4.3+0.3
29.5+2.2
The values given are expressed as tlte
mean* SD (calculated for six experirnents).
Coagulant Actiuities of Platelet Lipid and Lysed Platelets
The clot-promoting activity of the bovine platelet lipids was compared with that of lysed
platelets as a function of the phospholipid concentration. The results compiled in Fig 1 show
that at low phospholipid concentration (between t and 50 nmol/ml of lipid added) there is a
sharp decrease in clotting time which is identical for sonicated vesicles of extracted lipid and
lysed platelets. At higher lipid concentrations the clot-promoting activities of both prepa-
rations start to deviate. For lipid vesicles a minimal clotting time of 27 *0'4 s (mean* SD) was
found at about 100 nmol/ml of lipid added. Lysed platelets had a minimal clotting time of
18 + 0'3 s at a phospholipid concentration of750 nmoli ml. Above the most active phospholipid
concentration, both preparations showed a gradual decrease in clotting activity, but lysed
platelets were found to remain more active than the lipid extracts.
Factor V Activity oJ Cel-fltered Platelets
The results shown in Fig 1 and the finding that lysis of gel-filtered platelets produces release
of factor V activity (Breederveld et al, 1975; Osterud et al, 1"977) prompted us to investigate
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TanrE III. Factor V activity ofgel-filtered platelets
Matuial
Clotting time
inJactor V Percentage
assay (s) factor V
Whole platelets 48* 1'5
Sonicated platelets 32+1'0
Once frozen-and-thawed platelets 32+1'0
Buffer 205+7'0
The platelet suspensions u ed in the factor V assay con-
tained 2 x 10e platelets/ml. Sonicated platelets were obtained
as described in the text. The clotting times are expressed as
the mean * SD.
factor V (or Va) concentration on a lipid basis as in lysed platelets. For this purpose, 1000 nmol
of lipid/ml were made 5oh in factor V or 0.25oA in factor Va and further diluted with Tris
buffer for use in the coagulation assays. As shown inFig2, these additions of factor V (or Va)
had no influence on the clotting times at phospholipid concentrations up to 50 nmol/mlof lipid
added. At higher lipid concentrations, however, the effects of factor V or Va are clearly
noriceable. For the mixtures of platelet lipid with both factor V or factor Va the minimal
clotting time was found to be decreased to 20*0.3 s and was reached at higher phospholipid
concenrrarions (approx. 500 nmol/ml of lipid added) as compared to lipids alone. Nevertheless,
lysed platelets were still found to be more active.
In subsequent experiments the amounts of factor V and factor Va added to 1000 nmol of
sonicated lipid per ml were increased to 1.5o/o and0'75oh, respectively. As demonstrated in Fig
3, this three-fold increase in factor V (or Va) changed the clot-promoting behaviour of the lipid
vesicles to become identical to that of lysed platelets over the whole range of phospholipid
concentrations tested. Whereas platelet lipid alone had a minimal clotting time of 2I * 0'4 s at a
phospholipid concenrration of about 100 nmol/ml (cf. Fig 1) platelet lipids with 15oh of factor
y or 0.75oh of factor Va (both in 1000 nmol phospholipid per ml) as well as lysed platelets were
found to have a minimal clotting time of about 18+0'3 s at a lipid concentration of about 750
nmol/ml.
Experiments with Lower Factor X Concentrations in the Prothrombinase Assay
In the experiments described above, delipidated bovine plasma was used in the prothrom-
binase assay (compare Tans et a\,7979).In this plasma, factor X concentrations (assayed
according to Hemker et al,1972) were found to be normal whereas factor V was decreased to
about 35o/o of the normal plasma value.
It can be argued that if the coagulant advantage of lysed platelets over extracted platelet
lipids at higher phospholipid concentrations were due to platelet factor V, this difference
should disappear on decreasing the factor X concentration in the prothrombinase assay to,such
an extent that factor V will never be rate-limiting. Therefore the clotting behaviour of lysed
1.
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Ftc 3. Clotting times as a function of the logarithm of concentration of lipid added, expressed in
nmol/ml, for sonicated vesicles of lipid extracted from bovine platelets (o), for sonicated platelets
(o), and for vesicles of platelet lipid prepared at a concentration of 1000 nmol/ml, then made either
l5o/o of factor V(r) ot 0'75o/o of factor Va (v) and further diluted with Tris buffer. Further
conditions are the same as in Fig 1.
Frc 4. Clotting times as a function of the logarithm of concentration of lipid added, expressed in
nrnol/ml. In the prothrombinase assay use was made of delipidated bovine plasma and vesicles of
lipid from bovine platelets (o), delipidated bovine plasma and lysed bovine platelets (o), a 1:9
(v/v) mixture of delipidated bovine plasma and factor X-deficient plasma, and vesicles of lipid
from bovine platelets (r), the same plasma mixture and lysed bovine platelets (o), a 1:19 (v/v)
mixture of delipidated bovine plasma and factor X-deficient plasma, and either lipid vesicles (r) or
lysed platelets (a), and a 1:24 (vlv) mixture of delipidated bovine plasma and factor X-deficient
plasma and either lipid vesicles (v) or lysed platelets (v). Further conditions are the same as in Fig 1.
platelets and lipid extracts was compared in mixtures of delipidated plasma and congenital
factor X-deficient plasma, delipidated in the same manner.
As shown in Fig 4, decreasing factor X concentrations not only increased the coagulation
time but also abolished the difference between lysed platelets and extracted platelet lipids. At
1 :9 (v/v) mixtures of delipidated plasma and factor X-deficient plasma the higher clot-pro-
moting activity of lysed platelets is smaller but still apparent, while this difference is completely
diminished with mixtures of delipidated plasma and factor X-deficient plasma of 7: 19 (v/v) or
l : 24  ( v l v ) .
Comltarison of Procoagulant Actiuity of Platelet Lipids with Some Mixtures of Individual Lipids
It is generally accepted that lipid mixtures possess a higher clot-promoting activity than
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individual lipid classes (for recent review seeZwaal,1978). Therefore the coagulant activity of
some equimolar binary and ternary mixtures of synthetic dioleoyl phospholipids was com-
pared with that of extracted platelet lipids. As shown in Table IV, mixtures containing
phosphatidylserine show the highest clot-promoting activity. Moreover, addition of choles-
terol to phosphatidylserine-containing mixtures make them equivalent to platelet lipids.
Substitution of dioleoyl phosphatidylserine by plant phosphatidylinositol gave considerable
reduction in procoagulant activity.
Tasrr IV. Comparison of the coagulant activities of equimolar binary
and ternary mixtures of lipids present in platelet membranes
Minimal clotting
time (s)
Phospholipid
concentfdilon
at minimal clotting
time (nmollml of
lipid added)
ng phospholipid
per ml oJ test
solution
Platelet lipid
PC/PS
PC/PS/cholesterol
PE/PS
PC/PE/PS
PC/PE
PC/PI
Tris buffer
1 .5  x  104
1.0  x  104
1.5  x  104
3.0 x 104
1.5  x  104
15.0 x 104
15.0 x 104
21+0.4
24+0.6
27+0.4
25 + 0.5
24+0.5
60+ 1.5
33+ 1.0
225+7.0
75
50
75
150
75
750
750
Abbreviations: PC:dioleoyl phosphatidylcholine; PS:dioleoyl
phosphatidylserine; PE:dioleoyl phosphatidylethanolamine; PI:
phosphatidylinositol from plant.
The clotting times are expressed as the mean* SD.
DISCUSSION
The influence of platelets or phospholipids on the clotting time of plasma in the presence of
activation enzyme RVV-X provides direct information on their role in thrombin formation
from prothrombin. Since factor X is activated by incubation with RVV]X and CaCl2prior to
additionof platelets or lipids no contributions of their accelerating effect on the earlier steps in
coagulation are to be expected.
The results clearly demonstrate that at low lipid concentrations (up to 50 nmol/ml of lipid
added), there is no difference in procoagulant activity (platelet factor 3 ectivity) between
vesicles of platelet lipids and lysed platelets.
Apparently, in this concentration range the amount of available lipid surface is rate-limiting,
indicating that the more phospholipid membrane is provided the more prothrombinase
complexes will be formed with a resultant decrease in coagulation time (Tans el al, 1979).lf
platelets were to contain a more active lipoprotein component not present in isolated platelet
lipids, a procoagulant advantage of sonicated platelets would be present over the whole lipid
concentration range. Nevertheless, an advantage becomes only apparent at higher lipid
t27Platelet Factor V
concentrations where the clotting time reaches a minimum followed by a gradual 
increase'
This increase is thought to result fro- th. fact that the non-bound concentration of at least 
one
of the proteins involved approaches zero' so that addition of more lipid membranes 
will
decrease the density of the bound proteins and therefore their collision chance 
(Hemker, 1975;
Tans et at, t979). Since the bovine platelets used in this study also contain factor V activity
localized within the platelet, just as h", b..n observed for human platelets (Breederveld et al'
1975; @sterud et al,1977), arlrorrg., clot-promoting activity of lysed platelets as compared to
lipids alone might be expected 
"I 
hlgh..-lipid concentrations, if the number of non-bound
factor V molecules is exhausted earlier than factor Xa or prothrombin molecules' i'e' 
when
factor V is present in rate-limiting concentrations. That this is presumably the case follows
from the observation that addition of factor V (or Va) to the platelet lipids in the same
concentration as present in lysed platelets tends to decrease the clotting time and to increase 
the
phospholipid concentration at which maximal clot-promoting activity is observed' Signifi-
i"n,iy, 
"diition 
of factor V (or Va) to lipids decreases the clotting time only in the higher
phospholipid concentration range and .rtt at low phospholipid concentrations where 
the
amount of available lipid surface is rate-limiting and where platelet membranes have 
no
coagulant advantage orre. pl"telet lipids. However, a three-fold higher concentration of 
factor
V (or Va) appears to be necessary to make the procoagulant behaviour of the platelet lipids
indistinguishable from that of lysed platelets over the whole lipid concentration range' Such 
an
effect is to be expected when plat.let membranes bind factor v (or va) stronger than the
isolated phosPholiPids.
Various plausible explanations can be given to sustain this view: (a) The cytoplasmic surface
of the platelet plasma ,;,.e-b."rre has been shown to have a much more eflicient procoagulant
phospholipid composition than the exterior surface (chap et aI , 1977; Zwaal et al, 1'977) ' This
asymmetric orientation will be (partially) retained in a certain fraction of the vesicles obtained
from lysed platelets whereas in reconstituted vesicles all phospholipids will be homogeneously
partitioned, which is a less efiicient situation. (b) Platelet membrane fragments may have a size
and a structure different from that of phospholipid vesicles which might affect the 
binding
properties for factor V (or Va).
Even if platelet membranes have a stronger affinity for factor v, the amount of bound 
factor
V to plateiets differs insignificantly from that to lipids when the number of binding 
sites' i'e'
the amount of available"lipid membrane surface, is small since the surface will 
be saturated'
Platelet factor Va i, preromably identical to the factor Xa receptor site in activated 
or lysed
platelets (Miletich et;l, 1977, 1978a,b), but factor Xa also binds to phospholipids (Papahadjo-
poulos & Hanahan, 1964). When the number of factor Xa molecules is drastically reduced' it
."r, b. expected that factor Xa becomes the rate-limiting coagulation factor 
when the
phospholipid concentration is increased in the prothrombinase assay' The number 
of active
prothrombinase complexes decreases, which ."plrin, why the clotting time increases 
and less
ihospholipid -embran. is required for maximal activity. 
The observation that the difference
in coagulation behaviou. b.t*..n platelet membranes and platelet lipids disappears at 
lower
factor Xa concentrations strongly suggests that this difference can be attributed to additional
platelet factor V (or Va) arrd ,ttt to some unknown platelet lipoprotein with higher platelet
factor 3 activity than phospholipid alone. If this were the case, platelet membranes 
would still
have a higher clot-pro*oting 
"oirrity 
than phospholipids at lowered factor Xa concentrations'
Therefore, in our opinion there is no need to postulate a lipoprotein with higher platelet facto)3 activity than phospholipids (Marcus, 1969,197g; Watsti, iOZS;.
Finally, the experiments with synthetic lipids confir- th. g.rr..al notion that phosphatidyl-
serine is indeed the m-ost prominent procoagulant phosplohpid in platelei -#br".r.r.Equimolar mixtures of phosphatidylcholine, phosphatidy^lr..ir. and cholesterol show the
same,clot-promoting activity as extracted platelet lipids. in human and pig platelet plasma
membranes, phosphatidylserine has been shown to b. .lmost exclusivlely io.at.d'"t the
cytoplasmics ideof theplasmamembrane(Schick eta l ,7976;Chapeta l ,1977).Atpresentrhere
is little reason to suppose that the situation will be much diffeient in bovine platelets. Thepresent results strongly suggest that phosphatidylserine is an essenti"l .ornporrg^nt of plateletfactot 3' Therefore, increase in platelet factor 3 activity during platelet activation ,.q.r'ir.r, i'
addition to the appearance ofplatelet factor va on the outer sur"face, exposure ofphosphatidyl-
serine to interacting plasma coagulation factors. Experiments are in progress in our laboratory
to elucidate the mechanism by which this occurs.
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